Developer docs
API playgroundTry for free, no card

Search company profiles

Imactiv-3D

Full company profile

uuid003obzo

Namestring
Imactiv-3D
Legal namestring
Imactiv-3D SAS
Websiteurl
imactiv-3d.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Imactiv-3D SAS is a French preclinical imaging services company founded in 2015 in Toulouse by Jean-Michel Lagarde, a Pierre Fabre-trained optics and image analysis engineer. The company delivers 2D and 3D imaging and quantitative image analysis to pharmaceutical, biotech, cosmetics, and academic research clients engaged in preclinical studies. The business operates as a privately held SAS with a core team of four members (CEO, scientific advisor, image processing project manager, biology and imaging project manager) and is headquartered at Centre Pierre Potier in Toulouse.

The technical platform rests on two complementary modalities: 2D Whole Slide Imaging (WSI) using a VS200 Evident scanner with six objectives (2x–60x immersion) and multiple contrast modes, and 3D Light-Sheet Fluorescence Microscopy (LSFM) supporting volumetric imaging of whole organs at subcellular resolution with multi-channel acquisition. Service modules are organized by application domain — skin, adipose tissue, vascularization, brain, cardiac, obesity/metabolism, and 3D cell models — and combine acquisition with proprietary image processing pipelines (atlas-based brain quantification, vascular skeletonization, label-free elastin fiber analysis, automatic adipocyte detection). Carl Zeiss SAS is a core technology partner providing LSFM and WSI platforms.

Revenue is generated through project-based professional services contracts priced per quote, with a sales-led B2B go-to-market. Engagement is co-designed with clients through a dedicated interlocutor and framing workshops, and deliverables include quantitative metrics, publication-ready figures, and documented datasets. The company markets itself primarily through scientific publications, webinars, LinkedIn, and direct contact, with no disclosed funding, institutional investors, or public revenue figures.

Short descriptiontext

Imactiv-3D is a French preclinical imaging services company combining 2D whole slide imaging and 3D light-sheet fluorescence microscopy with biology and image analysis expertise to serve pharmaceutical, cosmetics, and academic research clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersToulouse, France
HQ citystring
Toulouse
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical imaging services, light-sheet fluorescence microscopy, whole slide imaging, quantitative image analysis, 3D histology
Industry4 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHAAAE
Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Diagnostic Imaging Centers621512
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Optical Instruments & Lenses3827
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Preclinical Imaging Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Preclinical Imaging Services
TypeProfessional Services
Description

Project-based professional services providing 2D and 3D imaging, image analysis, and quantitative metrics for preclinical research. Revenue generated through service contracts for specific studies or imaging projects.

imactiv-3d.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing adapted to project scope, endpoints, and number of samples

imactiv-3d.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Imactiv-3D provides project-based preclinical 2D and 3D imaging services combined with experimental biology expertise and quantitative image processing. Its core platforms are Whole Slide Imaging (WSI) for high-throughput histology and Light-Sheet Fluorescence Microscopy (LSFM) for whole-organ 3D volumetric imaging, with service modules across skin, adipose, vascular, brain, cardiac, obesity/metabolic, and 3D cell model applications delivered as custom engagements to pharmaceutical, cosmetics, and academic research clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Approximately 30,000 adipocytes quantified per slide
+2 more records
Product overview1 text field

Imactiv-3D provides preclinical imaging services organized around two core technology platforms: 2D Whole Slide Imaging (WSI) using VS200 Evident scanner for high-throughput histological analysis, and 3D Light-Sheet Fluorescence Microscopy (LSFM) for volumetric organ-level imaging. Service modules cover seven application domains (skin, adipose tissue, vascularization, brain, heart, obesity/metabolism, 3D cell models) with specialized sub-services for fiber analysis, lipid quantification, and atlas-based brain quantification. The portfolio combines 2D/3D imaging modalities with quantitative image analysis, segmentation, and publication-ready deliverables for pharmaceutical, cosmetics, and academic research clients.

Product and service11 records
12D Imaging / Histology (WSI)
CategoryPreclinical imaging service - 2D histology
Description

High-resolution whole slide imaging (WSI) digitization service for histological samples using a VS200 Evident scanner with 6 objectives (2x, 4x, 10x, 20x, 40x, 60x immersion), 180-slide capacity, and support for brightfield, polarized light, fluorescence, darkfield, and phase contrast modalities. Delivered with automated quantitative analysis using validated algorithms adapted to research endpoints, and intended for pharmaceutical, biotech, cosmetics, and academic research clients.

23D Imaging (LSFM)
CategoryPreclinical imaging service - 3D volumetric
Description

Light-sheet fluorescence microscopy (LSFM) service for 3D volumetric imaging of entire organs and tissues with subcellular resolution, supporting multi-channel simultaneous acquisition on volumes up to several cm³. Includes advanced 3D analysis such as segmentation, volumetric quantification, spatial analysis, and atlas registration for brain studies, aimed at preclinical research in pharma, biotech, cosmetics, and academia.

3Skin Imaging Services
CategoryPreclinical imaging service - dermatology
Description

Skin and cutaneous tissue imaging and analysis service combining 2D histology (WSI) for rapid cellular quantification and 3D LSFM for intact tissue visualization, including 3D fiber network analysis (orientation, density, structure) for dermatological and dermocosmetic research.

4Adipose Tissue Imaging
CategoryPreclinical imaging service - metabolic research
Description

Quantitative analysis of adipocytes and adipose tissue environment using combined 2D/3D imaging and lipid quantification, including adipocyte size analysis, lipid droplet quantification, differentiation studies, and microenvironment analysis covering vascular and connective tissue structures.

53D Vascularization Imaging
CategoryPreclinical imaging service - vascular research
Description

3D vascular and lymphatic network analysis service for preclinical studies, covering blood vessel characterization (density, diameter, branching, terminations), lymphatic vessel mapping, microcirculation analysis, and anti-angiogenic treatment evaluation across multiple organ types.

6Brain 3D Imaging
CategoryPreclinical imaging service - neuroscience
Description

Whole-brain LSFM imaging service with atlas registration for standardized quantification, including c-Fos activation analysis, target engagement studies, CNS biodistribution studies, and regional brain quantification using atlas/ROI-based analysis for neuroscience and CNS drug discovery research.

7Cardiac 3D Imaging
CategoryPreclinical imaging service - cardiovascular
Description

Whole-heart 3D imaging service covering fibrosis quantification (post-infarction, angiotensin treatment), coronary vascular network analysis (density, length, volume, organization), and ventricular volume measurements for cardiovascular preclinical research and drug efficacy validation.

8Obesity / Metabolic Studies
CategoryPreclinical imaging service - metabolic disease
Description

3D metabolic indicators service for obesity research, including organ-level phenotyping (volumes, spatial distributions, intra-organ heterogeneity), vascular/lymphatic/innervation network analysis (density, length, tortuosity, branching, connectivity), and adipose tissue architecture studies.

93D Cell Models Imaging
CategoryPreclinical imaging service - 3D cell models
Description

3D imaging analysis service for spheroid and organoid models, including in-toto immunostaining, antibody/sonda diffusion and penetration profiling, advanced phenotyping with multiplexing and co-staining, and morphometric organization analysis (size, circularity, necrosis, internal structures).

103D Fiber Analysis
CategoryPreclinical imaging service - fiber quantification
Description

Label-free 3D elastin fiber network analysis service using LSFM endogenous signal, providing quantitative metrics including useful volume, fiber volume density, total fiber length, linear density, and comparisons between conditions for anti-aging, photo-aging, firmness, and tissue repair research.

11Lipid Analysis
CategoryPreclinical imaging service - lipid quantification
Description

Quantitative lipid analysis service for obesity and adipose tissue metabolism research, measuring lipid droplet surface, mean diameter, droplet count per cell, differentiation percentage (Bodipy/DAPI colocalization), heterogeneity and size distribution, with optional fibro-inflammation analysis (collagen/fibronectin segmentation).

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1DIVA Expertise
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Featured partner logo on website indicating collaborative relationship in imaging expertise.

imactiv-3d.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Featured partner logo indicating research collaboration and scientific expertise exchange.

3Université Paul Sabatier
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner from Toulouse region, indicating research collaboration.

imactiv-3d.com
4CNRS
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Featured partner logo indicating scientific research collaboration.

imactiv-3d.com
Strategic tierCoreTypeTechnology or Integration
Description

Equipment partner providing LSFM and WSI imaging technology platforms. Zeiss is featured prominently as technology provider.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Regional metropolitan support indicating local ecosystem integration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Health-tech cluster member providing networking and business development support.

8AFSSI
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Association member for scientific imaging and innovation collaboration.

imactiv-3d.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Featured partner in preclinical pharmacology services.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner logo indicating imaging and information technology collaboration.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Digital pathology and WSI scanner manufacturer with service offerings. Comparable as a WSI instrumentation and digital pathology ecosystem player serving histology labs and CROs.

TypeEmerging player
Description

Digital pathology AI software and quantitative image analysis for pharma, biotech, and research organizations. Comparable in delivering automated quantitative tissue analysis for preclinical drug development workflows.

TypeDirect peer
Description

Digital pathology and tissue image analysis services for preclinical and clinical research. Directly comparable in offering quantitative histology, AI-driven image analysis, and pharmaceutical R&D deliverables.

TypeBroad incumbent
Description

Large global preclinical CRO offering comprehensive drug discovery and safety assessment services, including histology and imaging capabilities. Overlaps in serving pharma/biotech preclinical needs, but as part of a vastly broader portfolio.

TypeEmerging player
Description

Provider of automated tissue imaging and analysis solutions combining microscopy, image analysis software, and services. Comparable in combining imaging instrumentation with quantitative analysis for preclinical research.

TypeBroad incumbent
Description

Major life science and diagnostics instrumentation vendor with significant preclinical imaging product and services portfolio (e.g., IVIS, Opera). Comparable as an incumbent offering imaging instrumentation and services across the preclinical market.

7ImaBiotech
TypeDirect peer
Description

Preclinical molecular imaging CRO offering advanced 3D imaging (including MSOT/LSFM-style modalities) and quantitative analysis for pharma/biotech. Directly comparable as a specialized imaging services firm serving the same drug development customers.

TypeEmerging player
Description

Digital pathology AI software and image analysis services provider for pharma and research. Comparable in AI-driven quantitative image analysis applied to preclinical/clinical tissue samples.

9Biocellvia
TypeDirect peer
Description

Preclinical imaging and image analysis services provider specializing in 3D tissue imaging and quantitative histology. Closely aligned in technology stack (3D imaging + biology expertise) and B2B pharma/biotech services model.

TypeBroad incumbent
Description

Global life science testing services group with significant preclinical and biopharma service offerings including imaging-adjacent capabilities. Comparable as a broad life-sciences services incumbent; not specialized in 3D imaging.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Imactiv-3D

Preclinical Imaging Servicesimactiv-3d.com

Imactiv-3D is a French preclinical imaging services company combining 2D whole slide imaging and 3D light-sheet fluorescence microscopy with biology and image analysis expertise to serve pharmaceutical, cosmetics, and academic research clients.

What Imactiv-3D does

Imactiv-3D SAS is a French preclinical imaging services company founded in 2015 in Toulouse by Jean-Michel Lagarde, a Pierre Fabre-trained optics and image analysis engineer. The company delivers 2D and 3D imaging and quantitative image analysis to pharmaceutical, biotech, cosmetics, and academic research clients engaged in preclinical studies. The business operates as a privately held SAS with a core team of four members (CEO, scientific advisor, image processing project manager, biology and imaging project manager) and is headquartered at Centre Pierre Potier in Toulouse.

The technical platform rests on two complementary modalities: 2D Whole Slide Imaging (WSI) using a VS200 Evident scanner with six objectives (2x–60x immersion) and multiple contrast modes, and 3D Light-Sheet Fluorescence Microscopy (LSFM) supporting volumetric imaging of whole organs at subcellular resolution with multi-channel acquisition. Service modules are organized by application domain — skin, adipose tissue, vascularization, brain, cardiac, obesity/metabolism, and 3D cell models — and combine acquisition with proprietary image processing pipelines (atlas-based brain quantification, vascular skeletonization, label-free elastin fiber analysis, automatic adipocyte detection). Carl Zeiss SAS is a core technology partner providing LSFM and WSI platforms.

Revenue is generated through project-based professional services contracts priced per quote, with a sales-led B2B go-to-market. Engagement is co-designed with clients through a dedicated interlocutor and framing workshops, and deliverables include quantitative metrics, publication-ready figures, and documented datasets. The company markets itself primarily through scientific publications, webinars, LinkedIn, and direct contact, with no disclosed funding, institutional investors, or public revenue figures.

Imactiv-3D firmographics

Firmographics
Name
Imactiv-3D
Legal name
Imactiv-3D SAS
Website
https://imactiv-3d.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Imactiv-3D is a French preclinical imaging services company combining 2D whole slide imaging and 3D light-sheet fluorescence microscopy with biology and image analysis expertise to serve pharmaceutical, cosmetics, and academic research clients.
Ownership category
akta.pro rank

Imactiv-3D industry classification

Industry
Product category
Preclinical Imaging Services
NAICS
Scientific Research and Development Services (5417), Diagnostic Imaging Centers (621512)
SIC
Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHAAAE
Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Preclinical imaging services
  • Light-sheet fluorescence microscopy
  • Whole slide imaging
  • Quantitative image analysis
  • 3D histology

Where Imactiv-3D is headquartered

Location

Headquarters

HQ city
Toulouse
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Imactiv-3D business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Preclinical Imaging Services: Project-based professional services providing 2D and 3D imaging, image analysis, and quantitative metrics for preclinical research. Revenue generated through service contracts for specific studies or imaging projects.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Imactiv-3D product offering

Product offering

Core offering

Imactiv-3D provides project-based preclinical 2D and 3D imaging services combined with experimental biology expertise and quantitative image processing. Its core platforms are Whole Slide Imaging (WSI) for high-throughput histology and Light-Sheet Fluorescence Microscopy (LSFM) for whole-organ 3D volumetric imaging, with service modules across skin, adipose, vascular, brain, cardiac, obesity/metabolic, and 3D cell model applications delivered as custom engagements to pharmaceutical, cosmetics, and academic research clients.

Product overview

Imactiv-3D provides preclinical imaging services organized around two core technology platforms: 2D Whole Slide Imaging (WSI) using VS200 Evident scanner for high-throughput histological analysis, and 3D Light-Sheet Fluorescence Microscopy (LSFM) for volumetric organ-level imaging. Service modules cover seven application domains (skin, adipose tissue, vascularization, brain, heart, obesity/metabolism, 3D cell models) with specialized sub-services for fiber analysis, lipid quantification, and atlas-based brain quantification. The portfolio combines 2D/3D imaging modalities with quantitative image analysis, segmentation, and publication-ready deliverables for pharmaceutical, cosmetics, and academic research clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • 2D Imaging / Histology (WSI) High-resolution whole slide imaging (WSI) digitization service for histological samples using a VS200 Evident scanner with 6 objectives (2x, 4x, 10x, 20x, 40x, 60x immersion), 180-slide capacity, and support for brightfield, polarized light, fluorescence, darkfield, and phase contrast modalities. Delivered with automated quantitative analysis using validated algorithms adapted to research endpoints, and intended for pharmaceutical, biotech, cosmetics, and academic research clients.
  • 3D Imaging (LSFM) Light-sheet fluorescence microscopy (LSFM) service for 3D volumetric imaging of entire organs and tissues with subcellular resolution, supporting multi-channel simultaneous acquisition on volumes up to several cm³. Includes advanced 3D analysis such as segmentation, volumetric quantification, spatial analysis, and atlas registration for brain studies, aimed at preclinical research in pharma, biotech, cosmetics, and academia.
  • Skin Imaging Services Skin and cutaneous tissue imaging and analysis service combining 2D histology (WSI) for rapid cellular quantification and 3D LSFM for intact tissue visualization, including 3D fiber network analysis (orientation, density, structure) for dermatological and dermocosmetic research.
  • Adipose Tissue Imaging Quantitative analysis of adipocytes and adipose tissue environment using combined 2D/3D imaging and lipid quantification, including adipocyte size analysis, lipid droplet quantification, differentiation studies, and microenvironment analysis covering vascular and connective tissue structures.
  • 3D Vascularization Imaging 3D vascular and lymphatic network analysis service for preclinical studies, covering blood vessel characterization (density, diameter, branching, terminations), lymphatic vessel mapping, microcirculation analysis, and anti-angiogenic treatment evaluation across multiple organ types.
  • Brain 3D Imaging Whole-brain LSFM imaging service with atlas registration for standardized quantification, including c-Fos activation analysis, target engagement studies, CNS biodistribution studies, and regional brain quantification using atlas/ROI-based analysis for neuroscience and CNS drug discovery research.
  • Cardiac 3D Imaging Whole-heart 3D imaging service covering fibrosis quantification (post-infarction, angiotensin treatment), coronary vascular network analysis (density, length, volume, organization), and ventricular volume measurements for cardiovascular preclinical research and drug efficacy validation.
  • Obesity / Metabolic Studies 3D metabolic indicators service for obesity research, including organ-level phenotyping (volumes, spatial distributions, intra-organ heterogeneity), vascular/lymphatic/innervation network analysis (density, length, tortuosity, branching, connectivity), and adipose tissue architecture studies.
  • 3D Cell Models Imaging 3D imaging analysis service for spheroid and organoid models, including in-toto immunostaining, antibody/sonda diffusion and penetration profiling, advanced phenotyping with multiplexing and co-staining, and morphometric organization analysis (size, circularity, necrosis, internal structures).
  • 3D Fiber Analysis Label-free 3D elastin fiber network analysis service using LSFM endogenous signal, providing quantitative metrics including useful volume, fiber volume density, total fiber length, linear density, and comparisons between conditions for anti-aging, photo-aging, firmness, and tissue repair research.
  • Lipid Analysis Quantitative lipid analysis service for obesity and adipose tissue metabolism research, measuring lipid droplet surface, mean diameter, droplet count per cell, differentiation percentage (Bodipy/DAPI colocalization), heterogeneity and size distribution, with optional fibro-inflammation analysis (collagen/fibronectin segmentation).

Quantifiable outcome

  • Approximately 30,000 adipocytes quantified per slide
  • +2 more outcomes

Companies that use Imactiv-3D

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Imactiv-3D technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Imactiv-3D partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered minor and core.

  • DIVA ExpertiseminorStrategic or Co-development PartnerFeatured partner logo on website indicating collaborative relationship in imaging expertise.
  • INSERMminorStrategic or Co-development PartnerFeatured partner logo indicating research collaboration and scientific expertise exchange.
  • Université Paul SabatierminorStrategic or Co-development PartnerAcademic partner from Toulouse region, indicating research collaboration.
  • CNRSminorStrategic or Co-development PartnerFeatured partner logo indicating scientific research collaboration.
  • Carl Zeiss SAScoreTechnology or IntegrationEquipment partner providing LSFM and WSI imaging technology platforms. Zeiss is featured prominently as technology provider.
  • Toulouse MetropoleminorStrategic or Co-development PartnerRegional metropolitan support indicating local ecosystem integration.
  • EurobiomedminorStrategic or Co-development PartnerHealth-tech cluster member providing networking and business development support.
  • AFSSIminorStrategic or Co-development PartnerAssociation member for scientific imaging and innovation collaboration.
  • PhysiogenexminorStrategic or Co-development PartnerFeatured partner in preclinical pharmacology services.
  • IMLINFOminorStrategic or Co-development PartnerPartner logo indicating imaging and information technology collaboration.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Imactiv-3D competitors and assessment

Company assessment

Others

  • 3DHISTECH: Digital pathology and WSI scanner manufacturer with service offerings. Comparable as a WSI instrumentation and digital pathology ecosystem player serving histology labs and CROs.

Emerging players

  • Indica Labs: Digital pathology AI software and quantitative image analysis for pharma, biotech, and research organizations. Comparable in delivering automated quantitative tissue analysis for preclinical drug development workflows.
  • TissueGnostics: Provider of automated tissue imaging and analysis solutions combining microscopy, image analysis software, and services. Comparable in combining imaging instrumentation with quantitative analysis for preclinical research.
  • Visiopharm: Digital pathology AI software and image analysis services provider for pharma and research. Comparable in AI-driven quantitative image analysis applied to preclinical/clinical tissue samples.

Direct peers

  • Flagship Biosciences: Digital pathology and tissue image analysis services for preclinical and clinical research. Directly comparable in offering quantitative histology, AI-driven image analysis, and pharmaceutical R&D deliverables.
  • ImaBiotech: Preclinical molecular imaging CRO offering advanced 3D imaging (including MSOT/LSFM-style modalities) and quantitative analysis for pharma/biotech. Directly comparable as a specialized imaging services firm serving the same drug development customers.
  • Biocellvia: Preclinical imaging and image analysis services provider specializing in 3D tissue imaging and quantitative histology. Closely aligned in technology stack (3D imaging + biology expertise) and B2B pharma/biotech services model.

Broad incumbents

  • Charles River Laboratories: Large global preclinical CRO offering comprehensive drug discovery and safety assessment services, including histology and imaging capabilities. Overlaps in serving pharma/biotech preclinical needs, but as part of a vastly broader portfolio.
  • PerkinElmer: Major life science and diagnostics instrumentation vendor with significant preclinical imaging product and services portfolio (e.g., IVIS, Opera). Comparable as an incumbent offering imaging instrumentation and services across the preclinical market.
  • Eurofins Scientific: Global life science testing services group with significant preclinical and biopharma service offerings including imaging-adjacent capabilities. Comparable as a broad life-sciences services incumbent; not specialized in 3D imaging.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Imactiv-3D social profiles

Digital presence

Imactiv-3D compliance and trust

Trust signal

Compliance1 record

Imactiv-3D financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Imactiv-3D leadership team

Management profile

Number of profiles

Profiles4 records

Imactiv-3D funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Imactiv-3D M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imactiv-3D

What does Imactiv-3D do?

Imactiv-3D provides project-based preclinical 2D and 3D imaging services combined with experimental biology expertise and quantitative image processing. Its core platforms are Whole Slide Imaging (WSI) for high-throughput histology and Light-Sheet Fluorescence Microscopy (LSFM) for whole-organ 3D volumetric imaging, with service modules across skin, adipose, vascular, brain, cardiac, obesity/metabolic, and 3D cell model applications delivered as custom engagements to pharmaceutical, cosmetics, and academic research clients.

Is Imactiv-3D a public or private company?

Imactiv-3D is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Imactiv-3D founded?

Imactiv-3D was founded in 2015. It employs 1 to 10 people.

Where is Imactiv-3D based?

Imactiv-3D is headquartered in Toulouse, France, in the Europe region.

How does Imactiv-3D make money?

One revenue line is on record: preclinical Imaging Services.

Who are Imactiv-3D's main competitors?

3DHISTECH is listed as an others. Emerging players are Indica Labs, TissueGnostics and Visiopharm. Direct peers are Flagship Biosciences, ImaBiotech and Biocellvia. Broad incumbents are Charles River Laboratories, PerkinElmer and Eurofins Scientific.

Does Imactiv-3D have an API?

No public API is recorded for Imactiv-3D.

What industry is Imactiv-3D in?

Imactiv-3D's product category is Preclinical Imaging Services. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5417 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales